Dabrafenib Mesylate and Emtricitabine and Tenofovir Disoproxil Fumarate
Determining the interaction of Dabrafenib Mesylate and Emtricitabine and Tenofovir Disoproxil Fumarate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: Emtricitabine and tenofovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Emtricitabine and Tenofovir Tablets
- Dabrafenib Mesylate-Emtricitabine Capsules
- Dabrafenib Mesylate-Emtricitabine Solution
- Dabrafenib Mesylate-Emtricitabine, lopinavir, ritonavir, and tenofovir
- Dabrafenib Mesylate-Emtricitabine, nelfinavir, and tenofovir
- Dabrafenib Mesylate-Emtricitabine, rilpivirine, and tenofovir
- Emtricitabine and Tenofovir Disoproxil Fumarate-Dacarbazine
- Emtricitabine and Tenofovir Disoproxil Fumarate-Dacarbazine Intravenous, Injection
- Emtricitabine and Tenofovir Disoproxil Fumarate-Daclatasvir
- Emtricitabine and Tenofovir Disoproxil Fumarate-Daclatasvir Dihydrochloride
- Emtricitabine and Tenofovir Disoproxil Fumarate-Daclizumab
- Emtricitabine and Tenofovir Disoproxil Fumarate-Daclizumab Subcutaneous